Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence-Reference-Cited by-同舟云学术

Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence

Published:2017-04 Issue:4 Volume:27 Page:537-545
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Shi Rong-liang¹²,Qu Ning¹,Luo Ting-xian¹,Xiang Jun¹,Liao Tian¹,Sun Guo-hua¹,Wang Yu¹,Wang Yu-long¹,Huang Cai-ping¹,Ji Qing-hai¹

Affiliation:

1. Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

2. Department of General Surgery, Minhang Hospital, Fudan University, Shanghai, China.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2016.0228

Reference38 articles.

1. Cancer statistics, 2015

2. Risk factor analysis in differentiated thyroid cancer

3. Macroscopic extranodal invasion is a risk factor for tumor recurrence in papillary thyroid cancer

4. BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence

5. Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Protein Biomarker Screening for Thyroid Carcinoma Based on Cancer Proteomics Profiles;Biomedicines;2024-09-10

2. Immuntherapie von Schilddrüsenkarzinomen;TumorDiagnostik & Therapie;2024-08

3. Nearly Half of Patients with Anaplastic Thyroid Cancer May Be Amenable to Immunotherapy;Biomedicines;2024-06-12

4. Chronic Lymphocytic Thyroiditis with Oncocytic Metaplasia Influences PD-L1 Expression in Papillary Thyroid Carcinoma;Head and Neck Pathology;2024-03-08

5. Immuntherapie von Schilddrüsenkarzinomen;Angewandte Nuklearmedizin;2024-03